Cited by 80Liver physiology and pathologyLiver Disease and TransplantationLiver Disease Diagnosis and Treatment

Review article: the reversibility of cirrhosis

Sohrabpour, A. A., Mohamadnejad, M., Malekzadeh, R.·2012·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Cirrhosis is the end result of many types of chronic liver diseases. Recent developments in the understanding of the process of hepatic fibrogenesis have revealed that the process is a dynamic one and a capacity for recovery from any degree of fibrosis including those associated with cirrhosis is plausible. Aim: To review current evidence of histopathological reversibility following drug therapy of more common aetiologies of cirrhosis. Methods: A PubMed search was performed and the evidence for histopathological regression of advanced fibrosis/cirrhosis following drug therapy was reviewed as of the end of F ebruary 2012. Results: There is abundant clinical evidence in support of the idea of the reversibility of cirrhosis in patients with different aetiologies of advanced hepatic disease including viral, autoimmune and metabolic/infiltrative liver disease. Conclusions: The concept of cirrhosis has changed from being a form of static and irreversible entity to a dynamic and reversible diseases stage. Novel therapeutic strategies are under investigation to target specific steps in the process of fibrogenesis with the aim of reversing advanced fibrosis/cirrhosis.

Integrity signals

Registry

Crossref · 10.1111/apt.12044

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 108 · Cited by 80

Authors
Sohrabpour, A. A., Mohamadnejad, M., & Malekzadeh, R.
Affiliations
Shariati Hospital (IR)
Corresponding author
Malekzadeh, R.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2012-09-11
Volume
36
Issue
9
Pages
824-832
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2053711680
Cited by
80
References
108
Citations by year
2025: 5 · 2024: 5 · 2023: 9 · 2022: 8 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 9 · 2016: 7 · 2015: 7 · 2014: 9 · 2013: 9
FWCI
1.00
Type
journal article
Language
en
Open access
closed
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
Keywords
liver fibrosis, fibrogenesis, antifibrotic therapy, chronic liver disease, viral liver disease, autoimmune liver disease, metabolic liver disease
MeSH terms
Humans, Liver Cirrhosis, Severity of Illness Index, Disease Progression, Recovery of Function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review